← All candidates
86 insider filings on record.
86 filings on record.
CNTACentessa Pharmaceuticals plc
NASDAQ · Healthcare · $6.27B
$40.50
+0.00% · Jun 29
86 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 2 sells
▸ hover a marker for the filing · drag to zoom · 1 move explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$6.27B
Float
92.5M
60% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
81 more transactions on Pro →Context
Coverage
Eli Lilly (LLY) Acquires Centessa Pharmaceuticals to Advance Orexin Receptor 2 AgonistsInsider Monkey · 06-26Is It Too Late To Consider Centessa Pharmaceuticals (CNTA) After A 191% One Year Surge?Simply Wall St. · 05-03Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher?Insider Monkey · 06-29Sector Update: Healthcare Stocks Advance Late AfternoonMT Newswires · 06-24
The file stays open
86 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice